Unity Biotechnology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
38.40
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.65
|
-1.36
|
0.29
|
17.58%
|
|
2022-06-30
|
-2.80
|
-1.90
|
0.90
|
32.14%
|
|
2022-03-31
|
-2.57
|
-2.80
|
-0.23
|
-8.95%
|
|
2021-12-31
|
-3.85
|
-1.80
|
2.05
|
53.25%
|
|
2021-09-30
|
-3.71
|
-3.00
|
0.71
|
19.14%
|
|
2021-06-30
|
-3.07
|
-3.20
|
-0.13
|
-4.23%
|
|
2021-03-31
|
-3.79
|
-2.90
|
0.89
|
23.48%
|
|
2020-12-31
|
-4.71
|
-3.70
|
1.01
|
21.44%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-6.06
|
|
2021-12-31
|
-10.90
|
|
2020-12-31
|
-9.87
|
|
2019-12-31
|
-1.90
|
|
2018-12-31
|
-6.43
|
|
2017-12-31
|
-6.72
|